{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:47:52Z","timestamp":1741153672863,"version":"3.38.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.rcsop.2024.100557","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:35:01Z","timestamp":1734597301000},"page":"100557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Co-development of a community pharmacy training regarding fentanyl and xylazine test strips"],"prefix":"10.1016","volume":"17","author":[{"given":"Grace","family":"Marley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Viracola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainsley","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Locklear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayla","family":"Ostrach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delesha","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.rcsop.2024.100557_bb0010","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMicm2303601","article-title":"Xylazine-associated skin injury","volume":"388","author":"O\u2019Neil","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100557_bb0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/29767342231214472","article-title":"Xylazine-associated wounds and related health concerns among people who use drugs: reports from front-line health workers in 7 US states","volume":"45","author":"Carroll","year":"2024","journal-title":"Subst Use Addict J"},{"key":"10.1016\/j.rcsop.2024.100557_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110985","article-title":"Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services","volume":"252","author":"Wagner","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rcsop.2024.100557_bb0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the southeastern United States","volume":"63","author":"Peiper","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.rcsop.2024.100557_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","article-title":"Use of rapid fentanyl test strips among young adults who use drugs","volume":"61","author":"Krieger","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100557_bb0035","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/ijerph19042230","article-title":"The impact of the COVID-19 pandemic on drug use behaviors, fentanyl exposure, and harm reduction service support among people who use drugs in rural settings","volume":"19","author":"Bolinski","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.rcsop.2024.100557_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rcsop.2024.100557_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"author":"Harm Reduction Project. 50 State DCE Fact Sheet 2023","key":"10.1016\/j.rcsop.2024.100557_bb0050"},{"key":"10.1016\/j.rcsop.2024.100557_bb0055","unstructured":"Legislative Analysis and Public Policy Association. 2023 State of the States: Legislative Roadmap for Reducing Overdose Deaths and Increasing Access to Treatment. n.d. (Published online November 2023. Accessed December 4, 2024). https:\/\/legislativeanalysis.org\/wp-content\/uploads\/2023\/12\/2023-State-of-the-States.pdf."},{"key":"10.1016\/j.rcsop.2024.100557_bb0060","doi-asserted-by":"crossref","unstructured":"Chung EO, Patel SV, Wenger LD, et al. Distributing Safer Smoking Pipes Increases Engagement with Harm Reduction Services in the United States: Findings from the National Survey of Syringe Services Programs. n.d. (Published online July 1, 2024:2024.06.28.24309683). doi:https:\/\/doi.org\/10.1101\/2024.06.28.24309683.","DOI":"10.1101\/2024.06.28.24309683"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12954-022-00664-y","article-title":"Responding to a surge in overdose deaths: perspectives from US syringe services programs","volume":"19","author":"Frost","year":"2022","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.rcsop.2024.100557_bb0070","article-title":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; making a case for xylazine test strips","volume":"4","author":"Reed","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-021-00517-0","article-title":"Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study","volume":"18","author":"Parry","year":"2021","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100557_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/pharmacy11020056","article-title":"Advancing public health through community pharmacy practice","volume":"11","author":"DiPietro","year":"2023","journal-title":"Pharmacy"},{"key":"10.1016\/j.rcsop.2024.100557_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12954-023-00739-4","article-title":"North Carolina pharmacists\u2019 willingness to sell fentanyl test strips: a survey study","volume":"20","author":"Marley","year":"2023","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100557_bb0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.japh.2023.12.015","article-title":"The availability of fentanyl test strips in Georgia community pharmacies","volume":"64","author":"Rawal","year":"2024","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2024.100557_bb0095","doi-asserted-by":"crossref","unstructured":"Ruth A, Wutich A, Bernard HR. The Handbook of Teaching Qualitative and Mixed Research Methods: A Step-by-Step Guide for Instructors. 2023. doi:https:\/\/doi.org\/10.4324\/9781003213277.","DOI":"10.4324\/9781003213277"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100557_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1017\/cts.2018.14","article-title":"A community engagement advisory board as a strategy to improve research engagement and build institutional capacity for community-engaged research","volume":"2","author":"Matthews","year":"2018","journal-title":"J Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100557_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12961-017-0271-z","article-title":"Engaging stakeholders: lessons from the use of participatory tools for improving maternal and child care health services","volume":"15","author":"Ekirapa-Kiracho","year":"2017","journal-title":"Health Res Policy Syst"},{"issue":"10","key":"10.1016\/j.rcsop.2024.100557_bb0110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/gim.2013.127","article-title":"Stakeholder engagement: a key component of integrating genomic information into electronic health records","volume":"15","author":"Hartzler","year":"2013","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100557_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1353\/cpr.2013.0028","article-title":"Rural community-academic partnership model for community engagement and partnered research","volume":"7","author":"Baquet","year":"2013","journal-title":"Prog Community Health Partnersh Res Educ Action"},{"issue":"11","key":"10.1016\/j.rcsop.2024.100557_bb0120","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.sapharm.2018.11.012","article-title":"Applying participatory design to a pharmacy system intervention","volume":"15","author":"Reddy","year":"2019","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/ADM.0000000000001244","article-title":"A brief online training to address pharmacists\u2019 willingness to dispense buprenorphine","volume":"18","author":"Carpenter","year":"2024","journal-title":"J Addict Med"},{"issue":"11","key":"10.1016\/j.rcsop.2024.100557_bb0130","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/s10995-019-02802-8","article-title":"Primary care Women\u2019s health screening: a case study of a community engaged human centered design approach to enhancing the screening process","volume":"23","author":"Foley","year":"2019","journal-title":"Matern Child Health J"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0135","doi-asserted-by":"crossref","DOI":"10.2196\/humanfactors.5443","article-title":"A human-centered design methodology to enhance the usability, human factors, and user experience of connected health systems: a three-phase methodology","volume":"4","author":"Harte","year":"2017","journal-title":"JMIR Hum Factors"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100557_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/NCQ.0000000000000161","article-title":"Quality improvement project to improve patient satisfaction with pain management: using human-centered design","volume":"31","author":"Trail-Mahan","year":"2016","journal-title":"J Nurs Care Qual"},{"key":"10.1016\/j.rcsop.2024.100557_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pecinn.2023.100196","article-title":"Exploring the impact of brief training on student pharmacists\u2019 naloxone communication skills","author":"Jankowski","year":"2023","journal-title":"PEC Innov"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100557_bb0150","article-title":"Effective educational videos: principles and guidelines for maximizing student learning from video content. CBE life","volume":"15","author":"Brame","year":"2016","journal-title":"Sci Educ"},{"key":"10.1016\/j.rcsop.2024.100557_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102291","article-title":"Availability of and attitudes towards harm reduction services: a rural pharmacy perspective","author":"Marley","year":"2024","journal-title":"J Am Pharm Assoc: JAPhA"},{"issue":"8","key":"10.1016\/j.rcsop.2024.100557_bb0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2105\/AJPH.2024.307681","article-title":"Rapid response to the legalization of fentanyl test strips in alabama: An academic\u2013community partnership","volume":"114","author":"McCollum","year":"2024","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12954-023-00882-y","article-title":"A qualitative assessment of key considerations for drug checking service implementation","volume":"20","author":"Rose","year":"2023","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.rcsop.2024.100557_bb0175","article-title":"Alabama community pharmacists\u2019 knowledge and perceptions regarding fentanyl test strips: a cross-sectional survey","author":"Woods","year":"2024","journal-title":"J Am Pharm Assoc: JAPhA"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sapharm.2013.03.002","article-title":"A meta-narrative review of recorded patient\u2013pharmacist interactions: Exploring biomedical or patient-centered communication?","volume":"10","author":"Murad","year":"2014","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100557_bb0185","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.sapharm.2024.02.001","article-title":"\u2018I go out of my way to give them an extra smile now:\u2019 a study of pharmacists who participated in respond to prevent, a community pharmacy intervention to accelerate provision of harm reduction materials","volume":"20","author":"Irwin","year":"2024","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.rcsop.2024.100557_bb0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2014.11.006","article-title":"Factors associated with provision of addiction treatment information by community pharmacists","volume":"52","author":"Hagemeier","year":"2015","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.rcsop.2024.100557_bb0195","article-title":"A content review of buprenorphine training programs for pharmacists","volume":"6","author":"Davis","year":"2022","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0200","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.japh.2022.10.031","article-title":"Readiness of community pharmacies to implement an opioid safety intervention","volume":"63","author":"Floyd","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100557_bb0205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.japh.2022.10.004","article-title":"Community pharmacist-provided opioid intervention frequencies and barriers","volume":"63","author":"Nichols","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"12","key":"10.1016\/j.rcsop.2024.100557_bb0210","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.sapharm.2018.07.008","article-title":"Factors associated with how often community pharmacists offer and dispense naloxone","volume":"15","author":"Carpenter","year":"2019","journal-title":"Res Soc Administ Pharmacy: RSAP"},{"key":"10.1016\/j.rcsop.2024.100557_bb0215","unstructured":"\u201cPharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review - J Am Pharm Assoc.\u201d Accessed December 9, 2024. https:\/\/www.japha.org\/article\/S1544-3191(19)30320-6\/fulltext."},{"issue":"8","key":"10.1016\/j.rcsop.2024.100557_bb0220","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.sapharm.2024.04.019","article-title":"ASAP: a pharmacy-level intervention to increase nonprescription syringe sales to reduce bloodborne illnesses","volume":"20","author":"Meyerson","year":"2024","journal-title":"Res Soc Administ Pharmacy: RSAP"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T21:52:53Z","timestamp":1741125173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276624001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"alternative-id":["S2667276624001549"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100557","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-development of a community pharmacy training regarding fentanyl and xylazine test strips","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100557"}}